Navigation Links
FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply
Date:9/2/2014

also possess hands-on experience helping their clients work with the FDA on obtaining clearance for IVD tests, medical devices, and similar products.

Distinguished presenters:
Jane Pine Wood, Attorney and Partner, McDonald Hopkins 
Kuo Tong, President & CEO, Quorum Consulting, Inc. 
Richard S. Cooper, Attorney and Partner, McDonald Hopkins 

The insights that will be offered during this webinar comprise essential information needed by laboratories to help them develop a game plan for LDTs. Presenters will share information with attendees about specific issues, in addition to opening up the session for live Q&A:

  • Why labs should not wait, but will benefit from decisive action now

  • Whether private payers will require FDA clearance of LDTs before issuing coverage and reimbursement determinations

  • How much of its existing steps for medical device review the FDA will incorporate into its LDT review requirements

  • Developing the business case for LDT clearance with lab owners and investors

  • Addressing the cost of LDT compliance

  • Timing of getting LDT tests to market

For more information about "FDA Prepares to Regulate LDTs: What You Must Know, What Your Lab May Need to Do, and Why You Should Prepare Now" and to view webinar details including presenter biographies and pricing, visit www.darkdaily.com/LDTwebinar. You may also contact Ron Martin<
'/>"/>

SOURCE The Dark Report
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Drugs from Isis Lipid Franchise Highlighted at European Society of Cardiology Congress 2014
2. Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014
3. Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014
4. Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
5. NCPA Launches Any Willing Pharmacy Campaign During August Congressional Recess
6. Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696
7. Edwards CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
8. Burzynski Clinic Presents the Results of a Phase II Study of Antineoplastons in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma at the Congress
9. Initial Studies of Channel Medsystems Cryothermic Therapy Demonstrate Preliminary Safety and Tolerability; Results Presented at the 42nd AAGL Global Congress
10. Philips Honored With Prestigious Respiratory Industry Excellence Award At AARC International Respiratory Congress
11. CareFusion Highlights Patient Safety, Actionable Data, Emergency Preparedness at American Association for Respiratory Care Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...   The issue: ... confirmed it contains two undeclared amphetamine-like drug substances that ... Empire Health Distribution of Terrebonne, Quebec ... Canada .  Jetfuel Superburn is promoted ... increased energy. What consumers should do ...
(Date:12/24/2014)... -- Kinex Pharmaceuticals announced today that the first patient ... Institute. KX2-361 (KX02), a dual src/pre-tubulin inhibitor, ... inhibitory activity against a broad panel of brain tumor ... (T98G), the most widely used chemotherapy for the treatment ... model, KX2-361 consistently clears brain tumors after 4 weeks ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
... Israel, December 20, 2011 During its meeting ... Governors of the Israel-U.S. Binational Industrial Research and Development ... new projects between Israeli and American companies. In addition to ... funding, boosting the total value of all projects to $22 ...
... a medical device company based in Worcester, MA developing ... Company,s $6 M Series B Preferred Stock offering closed ... been catalyzed by our technical progress and recent additions ... Scientific Advisory Board," explained Arthur Combs, Grove,s CEO. ...
Cached Medicine Technology:BIRD - Israel-US Binational Industrial R&D Foundation to Invest $8.1 Million in Nine new Projects 2BIRD - Israel-US Binational Industrial R&D Foundation to Invest $8.1 Million in Nine new Projects 3Grove Instruments Inc. Closes $6 M Series B Financing 2Grove Instruments Inc. Closes $6 M Series B Financing 3
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience of ... has introduced its new collection of 2015 prom dresses, ... new prom outfits are guaranteed to contain the perfect ... specially designed for 2015. Anyone who wants to buy ... website before Jan. 26, 2015, the deadline of the ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... even mild asthma among young inner-city children appears to be ... after diagnosis is a wise move as a hedge against ... according to a study from the Johns Hopkins Childrens Center. ... months after diagnosis, but six months may be too long ...
... Hopkins have evidence to explain why the supposedly natural act ... for life-threatening heart failure. , In a study ... (AHA) annual Scientific Sessions in Orlando, Fla., the Hopkins team ... pumping function to assess minute changes in the hearts of ...
... to do more to erase racial disparities, study suggests , ... pressure among heart failure patients vary widely by race and ... the Medical University of South Carolina, Mt. Pleasant, noted that ... but experts know little about actual rates of treatment and ...
... at AHA, including one from the Framingham Heart Study,link PAT ... ... ORLANDO, Fla., Nov. 4 Itamar Medical announced,confirmation of ... confirmation of PAT technology, Itamar Medical will now,promote clinical use ...
... increase the rate of coronary reperfusion (restoring blood flow ... the quality of care these patients received, according to ... coincide with its release at the American Heart Associations ... November 28 print issue of JAMA. , ST-segment ...
... Six Percent of Patients Discontinued Combination Therapy ... 4 New data released today,showed that ... proprietary extended-release niacin, Niaspan(R), and,simvastatin met its ... cholesterol minus HDL), while demonstrating improvements,on other ...
Cached Medicine News:Health News:Urban kids with asthma need more frequent check-ups, Hopkins study suggests 2Health News:Aging heart changes shape, shrinks and loses pumping function too 2Health News:Aging heart changes shape, shrinks and loses pumping function too 3Health News:Poorer Blood Pressure Control in Blacks With Heart Failure 2Health News:New Research Released at AHA Confirms Itamar's PAT Technology to Diagnose Early Cardiovascular Disease 2Health News:Statewide program helps improve quality of care for heart attack 2Health News:Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study 2Health News:Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study 3Health News:Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study 4Health News:Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study 5
... flexible lighting products. The first is available ... sizes 5", 10", and 15" (refers to ... These lights are for use in procedures ... second group of flexible lights is our ...
... Aaron manufactures two groups of flexible ... sterile and non-sterile in three different sizes ... flexible shaft portion of the light). These ... additional light is needed., ,The second ...
... toggle switches at off (center position) , ... pulses/10 s) , Tetanus: 50 Hz (50 pulses/s) ... (4 pulses/2 s); repeat (4 pulses/2 s; repeats ... 0-70 mA(HI range) 0-6.0mA (LO range) , Stimulus ...
... Operation: , Standby: A standby switch maintains power ... Twitch: 1 s (1 pulse/s) , Tetanus: ... pulses/2 s) , Output Current: Adjustable from 0-70 ... pulses (200-us duration) , Indicators: Battery LED (green) ...
Medicine Products: